STH Sitka Health

RNS Number:4339O
Sitka Health Fund VCT PLC
21 December 2006



PORTFOLIO UPDATE


   Offer for Altrix Healthcare plc ("Altrix") by CONCATENO PLC ("Concateno")


                                    Summary


Sitka Health Fund VCT ("Sitka VCT") is pleased to announce that the boards of
Concateno and Altrix have reached agreement on the terms of a recommended cash
offer for the entire issued and to be issued share capital of Altrix at 80.6
pence in cash for each ordinary share in Altrix (the "Offer").

The Offer values the issued and to be issued ordinary share capital of Altrix at
#11 million.


If the Offer proceeds to completion Sitka VCT will realise a gain of #1.35m on
its original investment of #0.4m. This would produce a return of over four
times, an IRR of 34% and a potential uplift of 3.7p per share.


Altrix, which is an unlisted public limited company, is one of the largest
commercial specialist oral fluid testing laboratories in Europe and one of the
top commercial drug testing laboratories in the UK.


Enquiries:


Laura Mugford Tel: 020 7282 1081


Citigate Dewe Rogerson




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCFFLFLQLBLFBK_SN_RNS4339O_SU_RNSTEST_XX_113626.2961_RZ__RT_R.xRoute.0.3
~

Sitka Health Fund Vct (LSE:STH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Sitka Health Fund Vct (LSE:STH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024